|
|||||
|
|
Application of a hemophilia mortality framework to the Emicizumab Global Safety Database |
|
| Authors: | Flora Peyvandi Johnny N. Mahlangu Steven W. Pipe Charles R. M. Hay Glenn F. Pierce Peter Kuebler Rebecca Kruse‐Jarres Midori Shima |
| Abstract: | |
| Keywords: | benchmarking cause of death hemophilia A mortality safety |